#BEGIN_DRUGCARD DB02543

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
36751

# Chemical_Formula:
C5H3NO2

# Chemical_IUPAC_Name:
pyrrole-2-carboxylate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Pyrrole-2-Carboxylate

# HET_ID:
PYC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H4NO2/c7-5(8)4-2-1-3-6-4/h1-3H,(H,7,8)/p-1

# InChI_Key:
InChIKey=LGLLLSXCRNWFKJ-UHFFFAOYSA-M

# Indication:
Not Available

# KEGG_Compound_ID:
C05942

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2543

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
109.0828

# Molecular_Weight_Mono:
109.016378345

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1L9D

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.34

# Predicted_LogS:
0.69

# Predicted_Water_Solubility:
6.21e+02 g/l

# Primary_Accession_No:
DB02543

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
3330246

# PubChem_Substance_ID:
46507534

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02717

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[O-]C(=O)c1cccn1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:14 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
D16521

# Drug_Target_1_GenBank_ID_Protein:
984788

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
soxA

# Drug_Target_1_Gene_Sequence:
>1173 bp
ATGAGCACACATTTTGATGTCATCGTTGTTGGAGCTGGATCAATGGGAATGGCGGCAGGT
TATCAATTAGCAAAGCAAGGAGTCAAAACATTATTAGTGGATGCATTTGATCCGCCGCAT
ACAAACGGAAGCCATCACGGTGATACTCGTATCATCCGCCATGCTTACGGTGAGGGAAGA
GAATATGTTCCTCTTGCATTAAGATCACAAGAGTTATGGTATGAACTAGAAAAAGAAACA
CACCATAAAATATTCACGAAAACGGGCGTACTCGTATTTGGTCCTAAAGGTGAATCGGCT
TTCGTTGCAGAAACGATGGAAGCGGCAAAGGAACATTCATTGACTGTTGATTTACTGGAA
GGTGATGAAATAAATAAGCGTTGGCCGGGTATAACGGTTCCGGAAAACTACAATGCTATT
TTCGAACCGAACTCAGGTGTATTATTCAGTGAAAATTGTATTCGTGCCTACCGCGAGTTA
GCTGAAGCGCGAGGTGCTAAAGTTCTAACACATACACGCGTTGAGGACTTTGACATTTCA
CCGGACTCAGTCAAAATCGAAACAGCAAATGGATCATACACAGCTGATAAATTAATTGTT
AGCATGGGAGCTTGGAATAGCAAACTACTTTCAAAACTAAATCTTGACATCCCATTACAG
CCATATCGTCAAGTGGTAGGTTTCTTTGAATCCGATGAATCAAAGTATAGCAATGATATT
GATTTCCCAGGATTCATGGTTGAAGTGCCAAATGGTATTTATTACGGATTCCCAAGCTTC
GGCGGCTGTGGATTGAAACTAGGATATCATACGTTCGGGCAGAAAATTGACCCTGATACA
ATTAATCGCGAATTTGGCGTTTATCCAGAAGATGAAAGTAATCTTCGCGCTTTCTTGGAA
GAATATATGCCAGGAGCAAATGGAGAGTTAAAAAGAGGGGCAGTCTGCATGTACACGAAA
ACATTAGATGAACATTTCATTATAGACTTACATCCTGAACATTCCAACGTAGTCATCGCT
GCCGGCTTCTCTGGCCATGGATTTAAGTTTTCCAGTGGAGTTGGTGAAGTGCTAAGTCAA
TTAGCTTTAACTGGTAAAACAGAGCACGATATTTCAATCTTCTCCATTAACCGTCCTGCT
TTGAAAGAATCGTTACAAAAAACAACTATCTAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
10220347	Wagner MA, Khanna P, Jorns MS: Structure of the flavocoenzyme of two homologous amine oxidases: monomeric sarcosine oxidase and N-methyltryptophan oxidase. Biochemistry. 1999 Apr 27;38(17):5588-95.
10368302	Trickey P, Wagner MA, Jorns MS, Mathews FS: Monomeric sarcosine oxidase: structure of a covalently flavinylated amine oxidizing enzyme. Structure. 1999 Mar 15;7(3):331-45.
10913293	Wagner MA, Jorns MS: Monomeric sarcosine oxidase: 2. Kinetic studies with sarcosine, alternate substrates, and a substrate analogue. Biochemistry. 2000 Aug 1;39(30):8825-9.
11087383	Zhao G, Qu J, Davis FA, Jorns MS: Inactivation of monomeric sarcosine oxidase by reaction with N-(cyclopropyl)glycine. Biochemistry. 2000 Nov 21;39(46):14341-7.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2380

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
43182

# Drug_Target_1_Name:
Monomeric sarcosine oxidase

# Drug_Target_1_Number_of_Residues:
390

# Drug_Target_1_PDB_ID:
1EL5

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01266	DAO

# Drug_Target_1_Protein_Sequence:
>Monomeric sarcosine oxidase
MSTHFDVIVVGAGSMGMAAGYQLAKQGVKTLLVDAFDPPHTNGSHHGDTRIIRHAYGEGR
EYVPLALRSQELWYELEKETHHKIFTKTGVLVFGPKGESAFVAETMEAAKEHSLTVDLLE
GDEINKRWPGITVPENYNAIFEPNSGVLFSENCIRAYRELAEARGAKVLTHTRVEDFDIS
PDSVKIETANGSYTADKLIVSMGAWNSKLLSKLNLDIPLQPYRQVVGFFESDESKYSNDI
DFPGFMVEVPNGIYYGFPSFGGCGLKLGYHTFGQKIDPDTINREFGVYPEDESNLRAFLE
EYMPGANGELKRGAVCMYTKTLDEHFIIDLHPEHSNVVIAAGFSGHGFKFSSGVGEVLSQ
LALTGKTEHDISIFSINRPALKESLQKTTI

# Drug_Target_1_Reaction:
sarcosine + H2O + O2 = glycine + formaldehyde + H2O2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the oxidative demethylation of sarcosine. Can also oxidize other secondary amino acids such as N-methyl-L- alanine

# Drug_Target_1_SwissProt_ID:
P40859

# Drug_Target_1_SwissProt_Name:
MSOX_BACB0

# Drug_Target_1_Synonyms:
EC 1.5.3.1
MSOX

# Drug_Target_1_Theoretical_pI:
5.28

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02543
